NCT Number: NCT00325806
Ramipril - Hypertension
Primary objective:
Mean values of systolic and diastolic office blood pressure
Secondary objectives:
Total mortality, occurrence of cardio- and cerebrovascular events, change of mean blood pressure (ABPM : Ambulatory Blood Pressure Monitoring) during the observation
Looking for future studies?
Notify MeKey information
Conditions
Age range
50 year–85 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- no previous antihypertensive therapy
- high-normal blood pressure according to the JNC-VI definition (systolic 130 - 139 and/or diastolic 85 - 89 mmHg)
Exclusion criteria
- antihypertensive therapy
- blood pressure greater 140/90 mmHg or ABPM greater 135/85 mmHg
Treatment and study plan
Primary outcomes
-
Mean systolic and diastolic 24-hour blood pressure in ABPM
Secondary outcomes
-
Overall mortality and total number of cardiovascular and cerebro-vascular events
-
Changes in mean blood pressure readings over time
-
Reasons for admissions to hospital/-stays
-
Occurrence of pathological fasting glucose levels in serum/pathological HbA1c levels.
Sponsors and collaborators
Lead sponsor
Sanofi
Industry
Registry information
Official study title
Prevention of Hypertension in Patients With High-Normal Blood Pressure With the Angiotensin-Converting-Enzyme-Inhibitor Ramipril - a Randomised Prevention Trial of the German Hypertension League.
Important dates
- Study start
- 2000
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- May 15, 2006
- Registry last updated
- Mar 8, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Improving Hypertension Medication Adherence for Older Adults
NCT05610059
Aging, Behavior
Tucson, Arizona, United States
View Trial DetailsSPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System
NCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsEffects of a 10-Week Zumba Program in Adults With Hypertension
NCT07735468
Behavior, Cardiovascular Diseases
Osuna, Sevilla, Spain
View Trial DetailsGenetics of Type 2 Diabetes in West Africans
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial Details